Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 60/100

Termination Rate

10.5%

2 terminated out of 19 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results88% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (7)
P 1 (2)
P 2 (7)

Trial Status

Completed14
Terminated2
Not Yet Recruiting1
Withdrawn1
Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07114107Not ApplicableNot Yet Recruiting

Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion

NCT03928431Not ApplicableRecruiting

Restoration of Microbiota in Neonates

NCT04728711Phase 2CompletedPrimary

A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

NCT05098600Completed

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

NCT03603522Not ApplicableCompletedPrimary

Probiotics and Capsaicin Evoked Coughs

NCT03665701Not ApplicableCompletedPrimary

Characterization of the Inhibitory Effects of Fevipiprant (QAW039) on Activation of Eosinophils and ILC2 Cells by Prostaglandin D2 Metabolites

NCT04397081Completed

Atopic Diseases & Human Papilloma Virus

NCT02758548Phase 2CompletedPrimary

Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects

NCT02327234Not ApplicableCompletedPrimary

Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic Asthma

NCT01890161Phase 2CompletedPrimary

A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma

NCT01420003Not ApplicableCompletedPrimary

Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics

NCT01545245CompletedPrimary

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

NCT01049178Phase 2WithdrawnPrimary

Randomized Controlled Trial of Silymarin in Asthma

NCT00784459Phase 2CompletedPrimary

The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics

NCT00671593Phase 1TerminatedPrimary

Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge

NCT00644514Phase 1TerminatedPrimary

Genetics of Asthma - Bronchoscopy Studies

NCT01448954Phase 2CompletedPrimary

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

NCT00861211Phase 2CompletedPrimary

Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects

NCT01179256Not ApplicableCompletedPrimary

Effect of Supplemental Oral Curcumin in Patients With Atopic Asthma

Showing all 19 trials

Research Network

Activity Timeline